Secondary prevention after myocardial infarction

Translation of clinical trials into clinical practice.

Journal of internal medicine·2004

Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT)

Lancet (London, England)·2000

Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial).

Journal of the American College of Cardiology·2000

The agonising negative trend in monitoring of clinical trials.

Lancet (London, England)·2000

Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT).

Anesthesiology·1999

Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators.

Circulation·1999

Challenges in atrial fibrillation.

Advances in cardiology·2012

Antiplatelet therapy in stroke prevention.

Advances in cardiology·2012

Bleeding and the use of antiplatelet agents in the management of acute coronary syndromes and atrial fibrillation.

Advances in cardiology·2012

Stents and antiplatelet therapy.

Advances in cardiology·2012

Genetic considerations.

Advances in cardiology·2012

Protease-activated receptor-1 inhibitors: a novel class of antiplatelet agents for the treatment of patients with acute coronary syndrome.

Advances in cardiology·2012

Clinical Implications of Transmural Late Gadolinium Enhancement in Genotype-Positive Arrhythmogenic and Dilated Cardiomyopathy.

JACC. Clinical electrophysiology·2026

Body Composition in Heart Failure: A Magnetic Resonance Imaging and Dual X-Ray Absorptiometry Assessment in the UK Biobank Study.

JACC. Heart failure·2026

Anticoagulation and Antiplatelet Therapy in Chronic Subdural Hematoma: A Multicenter Evaluation.

Neurosurgery·2026

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study.

Alimentary pharmacology & therapeutics·2026

State of the Art: Personalized Antiplatelet Therapy by Genotype and Platelet Function Testing.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026

2026 ISH guidelines for the management of hypertension in Africa: the International Society of Hypertension (ISH) African Regional Advisory Group and the Pan African Society of Cardiology (PASCAR).

Journal of hypertension·2026

Related Experiment Videos

Secondary prevention after myocardial infarction

Related Concept Videos

Translation of clinical trials into clinical practice.

Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT)

Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial).

The agonising negative trend in monitoring of clinical trials.

Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT).

Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators.

Challenges in atrial fibrillation.

Antiplatelet therapy in stroke prevention.

Bleeding and the use of antiplatelet agents in the management of acute coronary syndromes and atrial fibrillation.

Stents and antiplatelet therapy.

Genetic considerations.

Protease-activated receptor-1 inhibitors: a novel class of antiplatelet agents for the treatment of patients with acute coronary syndrome.

Clinical Implications of Transmural Late Gadolinium Enhancement in Genotype-Positive Arrhythmogenic and Dilated Cardiomyopathy.

Body Composition in Heart Failure: A Magnetic Resonance Imaging and Dual X-Ray Absorptiometry Assessment in the UK Biobank Study.

Anticoagulation and Antiplatelet Therapy in Chronic Subdural Hematoma: A Multicenter Evaluation.

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study.

State of the Art: Personalized Antiplatelet Therapy by Genotype and Platelet Function Testing.

2026 ISH guidelines for the management of hypertension in Africa: the International Society of Hypertension (ISH) African Regional Advisory Group and the Pan African Society of Cardiology (PASCAR).

Related Experiment Videos

Secondary prevention after myocardial infarction

Related Concept Videos

Related Articles